Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Page 452
revolutionizing-ovarian-cancer-detection:-the-role-of-ai-in-enhancing-diagnoses
Posted inBiotechnology

Revolutionizing Ovarian Cancer Detection: The Role of AI in Enhancing Diagnoses

January 2, 2025
A recent groundbreaking study published in the esteemed journal Nature Medicine has emerged from the innovative research team at Karolinska…
Read More
neumora-stumbles-at-start-of-phase-3-depression-readout-run,-sending-stock-down-80%
Posted inBiotechnology

Neumora stumbles at start of phase 3 depression readout run, sending stock down 80%

January 2, 2025
Neumora Therapeutics’ big bet on a new era of neuroscience has delivered an age-old result. The first of three late-stage…
Read More
valo-health-abandons-rock-inhibitor-after-phase-2-diabetic-retinopathy-fail
Posted inBiotechnology

Valo Health abandons ROCK inhibitor after phase 2 diabetic retinopathy fail

January 2, 2025
Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading…
Read More
beigene,-brii-and-ideaya-ring-in-2025-with-deal-news,-betting-billions-in-biobucks-on-prospects
Posted inBiotechnology

BeiGene, Brii and Ideaya ring in 2025 with deal news, betting billions in biobucks on prospects

January 2, 2025
Dealmakers at BeiGene, Brii Biosciences and Ideaya Biosciences had a busy end to the year, sharing news of agreements for…
Read More
cash-strapped-viracta-ends-phase-2-study-of-lead-cancer-drug-as-it-mulls-remaining-options
Posted inBiotechnology

Cash-strapped Viracta ends phase 2 study of lead cancer drug as it mulls remaining options

January 2, 2025
Cash-strapped Viracta Therapeutics is continuing to reduce its options in order to stay afloat. Less than two months after announcing…
Read More
pfizer-cuts-losses-on-near-approval-hemophilia-gene-therapy,-adding-to-troubled-sangamo’s-woes
Posted inBiotechnology

Pfizer cuts losses on near-approval hemophilia gene therapy, adding to troubled Sangamo’s woes

January 2, 2025
Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up…
Read More
festive-biotech-m&a-spree-sees-poolbeg-combine-with-hookipa,-while-vincerx-braces-for-layoffs
Posted inBiotechnology

Festive biotech M&A spree sees Poolbeg combine with Hookipa, while Vincerx braces for layoffs

January 2, 2025
The festive season may be a chance to rest up and recharge—but tell that to biotech dealmakers, who have been…
Read More
roche-returns-to-innovent-biologics-with-new-$1b-biobucks-adc-drug-deal
Posted inBiotechnology

Roche returns to Innovent Biologics with new $1B biobucks ADC drug deal

January 2, 2025
Roche is wasting no time in getting out its checkbook in 2025, signing a new biobucks-heavy pact that aims to…
Read More
transforming-thermal-control:-breakthrough-cerium-oxide-thermal-switches-set-new-standards-in-heat-management
Posted inBiotechnology

Transforming Thermal Control: Breakthrough Cerium Oxide Thermal Switches Set New Standards in Heat Management

January 1, 2025
In a significant breakthrough that could redefine thermal management systems, researchers from Hokkaido University have introduced a remarkable advancement in…
Read More
university-of-iowa-research-uncovers-pathway-of-ebola-to-skin’s-surface
Posted inBiotechnology

University of Iowa Research Uncovers Pathway of Ebola to Skin’s Surface

January 1, 2025
Ebola Virus Dynamics: New Insights into Infection and Transmission Pathways Ebola virus disease (EVD) has long been a subject of…
Read More

Posts pagination

Previous page 1 … 450 451 452 453 454 … 464 Next page

Privacy Policy    Terms

Scroll to Top